Nobuhiro Kanaji
8PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 28, 2025
Antitumor Effects of Combination Therapy with Oncolytic Vaccinia Virus and Tepotinib on Lung Cancer Cells.Takuya Inoue, Nobuhiro Kanaji, Takafumi Nakamura
|Mar 26, 2025
Immune Checkpoint Inhibitor-Induced Insidiously Progressive, Fatal Interstitial Lung Disease.Nobuhiro Kanaji, Naoki Watanabe, Takuya Inoue
|Dec 19, 2024
Prevalence and clinical features of interstitial lung disease in patients with psoriasis.Nobuhiro Kanaji, Noriyuki Misaki, Makiko Murota
|Oct 21, 2024
Establishment of lung cancer cell lines and tumorigenesis in mice from malignant pleural effusion in patients with lung cancer.Nobuhiro Kanaji, Masanao Yokohira, Takuya Inoue
|Jan 24, 2024
Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005).Nobuhiro Kanaji, Eiki Ichihara, Takaaki Tanaka
|Dec 01, 2023
Superior vena cava syndrome induced by lung hyperinflation in chronic obstructive pulmonary disease: a case report.Nobuhiro Kanaji, Naoki Watanabe, Takuya Inoue
Pageof 2
